| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 142493 | Null | 0.00423163567577551 | 0.30560042 |
| NSC 605607 | Null | 0.00423163567577551 | 0.46398197 |
| NSC 617823 | 4-Morpholinepentanoic acid, .alpha.-(phenylmethylene)- .beta.-oxo-, ethyl ester, hydrochloride | 0.00423163567577551 | 0.43050755 |
| NSC 618296 | Null | 0.00423163567577551 | 0.26171757 |
| NSC 648365 | Insulin-Methotrexate conjugate | 0.00423163567577551 | 0.31859875 |
| NSC 683416 | 1H-Pyrrole-2-carboxamide, N-[2-[[[4-[[5,5a,6,8,8a,9-hexahydro- 5-(4-hydroxy-3,5-dimethoxyphenyl)- 6-oxofuro[3',4':6,7]naphtho[1,2-d]-1,3-dioxol-9-yl]amino] phenyl]amino]carbonyl]-1-methyl-1H-pyrrol-4 | 0.00423163567577551 | 0.59245446 |
| NSC 701375 | 3-Pyridinecarbonitrile, 6-[4-[(7-chloro-4-quinolinyl)amino]phenyl]-1,2-dihydro- 2-imino-4-(4-nitrophenyl)- | 0.00423163567577551 | 0.42007479 |
| NSC 712742 | Null | 0.00423163567577551 | 0.21317419 |
| NSC 723888 | 3-benzyl-2-methyl-4,5-dioxo-4,5-dihydro-3H-benzo[e]indole-1-carboxylic acid, ethyl ester | 0.00423163567577551 | 0.10046103 |
| NSC 724448 | Null | 0.00423163567577551 | 0.2113164 |